ALNY Trading Analysis - 09/10/2026 04:38 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for Alnylam Pharmaceuticals (ALNY) include:

• ALNY announced positive topline results from the HELIOS-B study of vutrisiran for the treatment of transthyretin-mediated amyloidosis (ATTR).
• The company reported a significant reduction in serum transthyretin (TTR) levels in patients treated with vutrisiran.
• ALNY received FDA orphan drug designation for its investigational therapy, cemdisiran, for the treatment of primary hyperoxaluria type 1 (PH1).

These recent developments could impact the stock price, as they demonstrate the company's progress in its pipeline and potential for future growth.

Fundamental Analysis:

Based on the provided fundamentals data:

• Total Revenue: $4,804,182,000
• Trailing EPS: $5.37
• Trailing P/E: 48.04
• Price-to-Book: 52.61
• Debt-to-Equity: 3.11
• Return on Equity (ROE): 54.14%
• Gross Margins: 79.79%
• Operating Margins: 20.81%
• Profit Margins: 15.26%

The company's high profit margins and ROE indicate strong operational performance. However, the high debt-to-equity ratio and P/E ratio may be concerns for some investors.

Current Market Position:

Current price: $247.51

Recent price action: The stock has been trading in a range with a slight downward trend.

Key support and resistance levels:

• Support: $246.42 (intraday low)
• Resistance: $272.08 (52-week high)

Technical Analysis:

SMA trends:

• 5-day SMA: $259.24
• 20-day SMA: $242.81
• 50-day SMA: $256.42

RSI (14): 63.26, indicating a slightly overbought condition.

MACD: Bullish, with a MACD line above the signal line.

Bollinger Bands: The stock price is near the middle band, indicating a neutral position.

30-day high/low: The stock is trading near the lower end of its 30-day range.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bearish

Call vs Put dollar volume:

• Call dollar volume: $31,070
• Put dollar volume: $652,170

The bearish sentiment in options flow may indicate near-term downward pressure on the stock.

Key Price Levels:

• Support: $246.42
• Resistance: $272.08
• Entry: $248.50
• Target: $260.00
• Stop Loss: $244.00

25-Day Price Forecast:

ALNY is projected for $245.00 to $255.00

Based on current trends, momentum, and indicators, the stock price may trade within this range in the next 25 days.

Defined Risk Strategy Recommendations:

Based on the price forecast, consider the following defined risk strategies:

1. Bull Call Spread: Buy 1 ALNY 261016C00240000 call, sell 1 ALNY 261016C00260000 call
2. Bear Put Spread: Buy 1 ALNY 261016P00240000 put, sell 1 ALNY 261016P00220000 put
3. Iron Condor: Sell 1 ALNY 261016C00240000 call, buy 1 ALNY 261016C00260000 call, sell 1 ALNY 261016P00220000 put, buy 1 ALNY 261016P00200000 put

Risk Factors:

• Technical warning signs: RSI overbought condition, potential bearish divergence in MACD
• Sentiment divergences: Bearish options flow vs. bullish technicals
• Volatility and ATR considerations: High ATR may indicate increased risk

Summary & Conviction Level:

Overall bias: Neutral

Conviction level: Medium

One-line trade idea: Consider defined risk strategies based on technical and sentiment analysis.